In the quiet laboratories and dusty tribal villages of Maharashtra, a young researcher named Sudam Laxman Kate once looked into a microscope and saw a problem that would claim the rest of his life.

It was 1972. Russian anthropologists had come to India to study genetic markers among tribal groups. At B.J. Medical College in Pune, Sudam—then a lecturer in biochemistry—was tasked with the fieldwork. They chose the Pawara community in Sahada taluka of Dhule district. Day after day he collected blood samples, carefully screening for markers. Then, unexpectedly, he found something no one in that region had documented before: a few carriers of the sickle cell trait… and one patient suffering from full sickle cell disease.

He took the findings to his mentor, Professor G.S. Mutalik. “This is the first time we are seeing this here,” Sudam said, his voice steady but urgent. “If it is present in one community, how many more are suffering silently?”

Mutalik looked at the young man and replied simply, “Then you must continue. This cannot be left half-done.”

That conversation became a lifelong commitment. Sudam began systematic surveys among tribal and Scheduled Caste populations across Maharashtra and later into neighbouring Gujarat and Madhya Pradesh. He organised health camps in remote forests and hills where roads barely existed. He screened more than two lakh people. Over the years he identified and helped treat more than three thousand patients with sickle cell disease—men, women and children whose red blood cells twisted into rigid sickle shapes under stress, causing excruciating pain crises, organ damage and shortened lives.

In the absence of a full cure, he focused on what could be done: early diagnosis, counselling, and practical care. In 1998, under the Maharashtra Arogya Mandal in Hadapsar, Pune—supported by the socialist visionary Dada Gujar—he helped establish the Sickle Cell Dawakhana in Dhadgaon tehsil of Nandurbar district. There, patients received diagnosis, guidance, and free treatment with an innovative polyherbal formulation called SC3 developed by the Mandal. Ayurveda was blended with modern understanding. “We have to use every resource we have,” he would tell younger colleagues. “Western medicine alone is not reaching these villages. We must combine approaches.”

Even into his eighties and nineties he continued travelling monthly to the remotest villages of Roshmal Budruk and beyond. Villagers who once suffered in silence now recognised the soft-spoken doctor who arrived with test kits and quiet determination. “Doctor, the pain comes like fire,” one young patient once told him during a crisis. Sudam placed a hand on the man’s shoulder. “I cannot take the fire away completely yet,” he answered, “but together we can learn to live with it, and protect the next generation.”

He organised national symposiums on tribal health, published research, and kept advocating for stronger diagnostic services in rural areas. “Since it is genetic,” he often repeated, “timely diagnosis is the key. Without screening in the villages, the disease will keep spreading quietly.”

In 2017 the California-based organisation Sickle Cell 101 named him Sickle Cell Advocate of the Year—the first Indian to receive the honour. Two years later, in 2019, the Government of India conferred the Padma Shri upon him for his pioneering work in medicine.

When the news came, the now elderly scientist, living in Magarpatta City, Pune, remained characteristically understated. Recognition was welcome, but the real measure of his life lay in the camps still running, the patients still being counselled, and the slow awakening of awareness about a disease long overlooked among India’s tribal communities.

Dr. Sudam L. Kate’s story is not one of dramatic laboratory breakthroughs or sudden fame. It is the quieter story of a man who, upon discovering a silent suffering in the blood of forgotten villages, chose never to look away—and spent more than five decades making sure the rest of the country began to see it too.